Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Revenue: 2019-2024

Historic Revenue for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to $10.0 million.

  • Caribou Biosciences' Revenue rose 8.60% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $10.0 million for FY2024, which is 71.01% down from last year.
  • As of FY2024, Caribou Biosciences' Revenue stood at $10.0 million, which was down 71.01% from $34.5 million recorded in FY2023.
  • Over the past 5 years, Caribou Biosciences' Revenue peaked at $34.5 million during FY2023, and registered a low of $9.6 million during FY2021.
  • Over the past 3 years, Caribou Biosciences' median Revenue value was $13.9 million (recorded in 2022), while the average stood at $19.4 million.
  • Its Revenue has fluctuated over the past 5 years, first surged by 148.91% in 2023, then slumped by 71.01% in 2024.
  • Over the past 5 years, Caribou Biosciences' Revenue (Yearly) stood at $12.4 million in 2020, then decreased by 22.35% to $9.6 million in 2021, then surged by 44.31% to $13.9 million in 2022, then spiked by 148.91% to $34.5 million in 2023, then plummeted by 71.01% to $10.0 million in 2024.